Researchers from the Dow University of Health Sciences (Department of Medicine) and Mayo Clinic–Rochester completed a meta-analysis of the role of selenium in lowering adverse cardiac surgery outcomes. The complete manuscript by Syeda Tayyaba Rehan, Hassan ul Hussain, Laiba Imran, Farea Eqbal, and Muhammad Sohaib Asghar is available in Frontiers in Cardiovascular Medicine. Below is a…
Login in to view this article:
You need to be logged in to view the rest of this article. Don't have an account? Register for one below.
Subscribe
0 Comments
Oldest